What happens when a real-life patient doesn't fit current guidelines and the clinical approach is unclear? A Saturday-morning session will look at glucose control and HbA1c goals in type 2 diabetes.
The session, “Annals of Internal Medicine Beyond the Guidelines: To What Target A1c Would You Treat This Patient with Diabetes?”, is a collaboration between Annals of Internal Medicine and Beth Israel Deaconess Medical Center Department of Medicine in Boston. Experts will present a case and invite discussants to review both the American College of Physicians and the American Diabetes Association guidelines and how to apply them to a specific patient in particular.
Audience members will watch a patient video, vote on the optimal target HbA1c for the patient, and listen to the opinions of the expert discussants. The session will also include an interactive question-and-answer period.
The rounds will be videotaped, and an interactive video will be posted on the Annals of Internal Medicine website. A manuscript based on the content of the rounds will appear in Annals of Internal Medicine later this year. The session will be held from 8:15 to 9:15 a.m. on Saturday in Room 122.